Metabolic associated fatty liver disease is a risk factor for chronic kidney disease.
Yoshitaka HashimotoYoshitaka HashimotoTakuro OkamuraNaoko NakanishiAkihiro OboraTakao KojimaMichiaki FukuiPublished in: Journal of diabetes investigation (2021)
MAFLD was associated with a risk of CKD, whereas FLD without MD was not a risk for CKD.